Agenus to participate in 4th annual evercore isi healthconx conference

Lexington, mass., nov. 17, 2021 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that dr. garo armen, chairman and chief executive officer of agenus and dr. steven o'day, chief medical officer, will participate in a fireside chat hosted by evercore on tuesday, november 30th, 2021 at 1:50 pm est.
AGEN Ratings Summary
AGEN Quant Ranking